← all research

Panel 2020-01-01..2026-08-31 | long k lowest-z / short k highest-z, dollar-neutral | held [t,t+1] | IS<2024-01-01/OOS>= | 15bps/unit turnover | random-rank placebo x500.

lookkFULL net SRIS net SROOS net SROOS gross SROOS retOOS DDbeta EWavg turnover
102-1.33-1.01-3.160.24-86.9%-87.3%-0.011.40
103-1.29-1.01-2.680.91-74.7%-75.7%-0.001.07
302-1.04-0.67-2.970.28-86.0%-86.7%-0.021.34
303-1.03-0.55-2.960.35-79.9%-80.4%-0.021.03
602-0.84-0.18-2.720.51-83.7%-84.1%-0.021.31
603-0.98-0.52-2.880.45-78.1%-78.0%-0.011.01

Cost mitigation — rebalance every 5 sessions (look 30, k 2)

variantavg turnoverIS net SROOS net SROOS gross SROOS retplacebo p
daily1.34-0.67-2.970.28-86.0%0.154
every 5d0.290.12-1.82-1.11-69.3%0.000

Placebo (look 30, k 2 — shuffle weights across coins each day)

  • daily OOS obs net SR -2.97 vs null mean -3.66/p95 -2.56 -> p 0.154

Verdict: REJECT

  • daily look 30 / k 2: OOS net SR -2.97, IS -0.67, placebo p 0.154, beta -0.02
  • every-5d look 30 / k 2: OOS net SR -1.82, IS +0.12, placebo p 0.000, beta -0.04
  • The gross book has a small positive OOS edge, but the premium z flips membership daily: turnover ~1.3x/day costs ~20bps/day, and even at a 5-day rebalance the selection does not clear the placebo. Market-neutral removed the beta but not the cost. REJECT; premium feed stays infrastructure.